Capital Investment Advisors LLC Purchases 1,399 Shares of Stryker Co. (NYSE:SYK)

Capital Investment Advisors LLC raised its stake in Stryker Co. (NYSE:SYK - Free Report) by 76.0% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,240 shares of the medical technology company's stock after acquiring an additional 1,399 shares during the quarter. Capital Investment Advisors LLC's holdings in Stryker were worth $1,206,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the stock. Vanguard Group Inc. raised its holdings in Stryker by 0.8% in the 4th quarter. Vanguard Group Inc. now owns 32,698,828 shares of the medical technology company's stock valued at $11,773,213,000 after acquiring an additional 252,188 shares during the period. Price T Rowe Associates Inc. MD raised its holdings in Stryker by 0.5% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 11,109,722 shares of the medical technology company's stock valued at $4,000,056,000 after acquiring an additional 54,693 shares during the period. FMR LLC raised its holdings in Stryker by 10.0% in the 4th quarter. FMR LLC now owns 8,034,844 shares of the medical technology company's stock valued at $2,892,946,000 after acquiring an additional 727,850 shares during the period. Geode Capital Management LLC raised its holdings in Stryker by 2.4% in the 4th quarter. Geode Capital Management LLC now owns 7,073,562 shares of the medical technology company's stock valued at $2,539,033,000 after acquiring an additional 168,436 shares during the period. Finally, Norges Bank bought a new position in Stryker in the 4th quarter valued at about $1,710,744,000. 77.09% of the stock is owned by institutional investors.

Insider Transactions at Stryker

In other news, Director Ronda E. Stryker sold 200,000 shares of Stryker stock in a transaction on Tuesday, May 6th. The shares were sold at an average price of $376.96, for a total transaction of $75,392,000.00. Following the transaction, the director now owns 3,417,326 shares in the company, valued at approximately $1,288,195,208.96. The trade was a 5.53% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 5.90% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the stock. Sanford C. Bernstein set a $450.00 price target on shares of Stryker in a report on Monday, May 5th. Needham & Company LLC reaffirmed a "buy" rating and set a $442.00 target price on shares of Stryker in a report on Friday, March 21st. Wall Street Zen cut shares of Stryker from a "buy" rating to a "hold" rating in a report on Friday, June 6th. Citigroup reaffirmed a "buy" rating and set a $455.00 target price (up from $443.00) on shares of Stryker in a report on Thursday, May 22nd. Finally, Truist Financial raised their target price on shares of Stryker from $390.00 to $400.00 and gave the stock a "hold" rating in a report on Monday, May 5th. Five research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company's stock. Based on data from MarketBeat.com, Stryker presently has an average rating of "Moderate Buy" and a consensus price target of $427.30.

Stryker Price Performance

Stryker stock traded down $4.02 during mid-day trading on Wednesday, reaching $381.03. The company had a trading volume of 792,341 shares, compared to its average volume of 1,330,630. Stryker Co. has a fifty-two week low of $314.93 and a fifty-two week high of $406.19. The company has a current ratio of 1.95, a quick ratio of 1.32 and a debt-to-equity ratio of 0.59. The company has a market cap of $145.43 billion, a P/E ratio of 49.10, a P/E/G ratio of 2.93 and a beta of 0.91. The business has a fifty day simple moving average of $370.53 and a 200 day simple moving average of $375.91.

Stryker (NYSE:SYK - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.84 EPS for the quarter, topping analysts' consensus estimates of $2.73 by $0.11. The company had revenue of $5.87 billion for the quarter, compared to analyst estimates of $5.68 billion. Stryker had a net margin of 13.25% and a return on equity of 23.58%. Stryker's revenue was up 11.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.50 earnings per share. On average, equities research analysts predict that Stryker Co. will post 13.47 earnings per share for the current year.

Stryker Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, July 31st. Stockholders of record on Monday, June 30th will be issued a dividend of $0.84 per share. The ex-dividend date is Monday, June 30th. This represents a $3.36 dividend on an annualized basis and a dividend yield of 0.88%. Stryker's dividend payout ratio (DPR) is presently 45.41%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.